l-carnitine human injection Injectable 500mg/ml (30ml) L Carnitine Injection 5ml, 2000

The results of the present clinical trial study provided promising evidence that early supplementation with L-carnitine in first-ever diagnosed ischemic stroke patients improves their anthropometric status and prevents muscle wasting, rapid weight loss, and malnourishment or worsening during hospitalization

We also found that ALCAR interferes with the paracrine effects of PCa secreted products on endothelial cells

This leads to a reduction in TCA cycle gene expression and oxygen consumption as well as an increase in lactate production and cell proliferation 89

doi:10.1016/j.ijdevneu.2015.02.008

C., Kassee, C., Besney, R., Bonato, S., Hull, L., Mandy, W., Szatmari, P., & Ameis, S